Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARM
11426
CALL
DELISTED
Farmer Brothers
FARM
| $29.9K | ﹤0.01% |
+11,600
| New | +$30.4K |
|
|
THRX
11427
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $29.9K | ﹤0.01% |
+11,112
| New | +$43.6K |
|
11428
Aterian
ATER
$7.55M
| $29.8K | ﹤0.01% |
7,597
-8,333
| -52% | -$43.1K |
|
|
TBIO
11429
CALL
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $29.6K | ﹤0.01% |
1,583
-778
| -33% | -$18.9K |
|
|
EFTR
11430
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $29.6K | ﹤0.01% |
1,976
+91
| +5% | +$1.58K |
|
|
STRM
11431
DELISTED
Streamline Health Solutions
STRM
| $29.6K | ﹤0.01% |
+2,038
| New | +$35.4K |
|
|
XNET
11432
Xunlei
XNET
$323M
| $29.6K | ﹤0.01% |
18,364
+5,847
| +47% | +$10.6K |
|
11433
PUT
Smartbird Inc
BIRD
$28M
| $29.5K | ﹤0.01% |
1,330
+715
| +116% | +$19.3K |
|
11434
CALL
Telos
TLS
$327M
| $29.4K | ﹤0.01% |
12,300
+1,300
| +12% | +$2.98K |
|
|
DNMR
11435
PUT
DELISTED
Danimer Scientific, Inc.
DNMR
| $29.4K | ﹤0.01% |
355
-273
| -43% | -$24.8K |
|
11436
Forafric Global PLC Warrants
AFRIW
$13.2M
| $29.3K | ﹤0.01% |
+24,657
| New | +$24.2K |
|
11437
AquaBounty Technologies
AQB
$6.85M
| $29.3K | ﹤0.01% |
6,120
+4,463
| +269% | +$26.4K |
|
11438
Sensus Healthcare
SRTS
$55.3M
| $29.1K | ﹤0.01% |
10,500
-5,090
| -33% | -$15.6K |
|
|
AGIG
11439
CALL
Abundia Global Impact Group
AGIG
$41.1M
| $29.1K | ﹤0.01% |
1,490
-570
| -28% | -$12.1K |
|
11440
PUT
Talphera
TLPH
$63.8M
| $29K | ﹤0.01% |
+50,000
| New | +$47.8K |
|
11441
CALL
Galectin Therapeutics
GALT
$402M
| $29K | ﹤0.01% |
15,100
-23,000
| -60% | -$37.8K |
|
11442
AtaiBeckley Inc
ATAI
$2.76B
| $29K | ﹤0.01% |
22,455
-1,798
| -7% | -$3.08K |
|
|
AOGOW
11443
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
| $28.9K | ﹤0.01% |
576,270
+379,203
| +192% | +$17.7K |
|
|
TTNP
11444
DELISTED
Titan Pharmaceuticals
TTNP
| $28.9K | ﹤0.01% |
+3,107
| New | +$33.3K |
|
11445
Zevia
ZVIA
$102M
| $28.9K | ﹤0.01% |
13,000
+2,437
| +23% | +$7.16K |
|
11446
CALL
Workhorse Group
WKHS
$34.3M
| $28.8K | ﹤0.01% |
23
+18
| +360% | +$46.3K |
|
|
EXK
11447
PUT
Endeavour Silver
EXK
$3.28B
| $28.7K | ﹤0.01% |
11,800
-2,200
| -16% | -$6.49K |
|
|
PLG
11448
Platinum Group Metals
PLG
$203M
| $28.7K | ﹤0.01% |
25,364
-25,705
| -50% | -$33.1K |
|
11449
SCYNEXIS
SCYX
$51.6M
| $28.3K | ﹤0.01% |
1,552
-877
| -36% | -$20.9K |
|
|
EVAX
11450
Evaxion A/S
EVAX
$27.9M
| $28.2K | ﹤0.01% |
655
-1,015
| -61% | -$51.2K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.